Assessing the effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in Belgium by means of an extended SEIQRD model and public mobility data Tijs W. Alleman 1,* , Jenna Vergeynst 1,2 , Lander De Visscher 2 , Michiel Rollier 2 , Elena Torfs 1 , the Belgian Collaborative Group on COVID-19 Hospital Surveillance 3,** , Ingmar Nopens 1 , and Jan M. Baetens 2 1 BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium 2 KERMIT, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium 3 Department of Epidemiology and Public Health, Sciensano, BE-1050 Brussels, Belgium * Corresponding author: Tijs W. Alleman, tijs.alleman@ugent.be ** Amir-Samy Aouachria, Kristof Bafort, Leïla Belkhir, Koen Blot, Nathalie Bossuyt, Steven Callens, Vincent Colombie, Sarah Cooreman, Nicolas Dauby, Paul De Munter, Robby De Pauw, Pieter Depuydt, Didier Delmarcelle, Mélanie Delvallee, Rémy Demeester, Thierry Dugernier, Caroline Gheysen, Xavier Holemans, Benjamin Kerzmann, Sarah Loof, Pierre Yves Machurot, Geert Meyfroidt, Philippe Minette, Jean-Marc Minon, Saphia Mokrane, Catherine Nachtergal, Séverine Noirhomme, Denis Piérard, Camelia Rossi, Carole Schirvel, Erica Sermijn, Ben Serrien, Frank Staelens, Fabio Taccone, Filip Triest, Dominique Van Beckhoven, Eva Van Braeckel, Nina Van Goethem, Jens Van Praet, Anke Vanhoenacker, Roeland Verstraete, Elise Willems, Chloé Wyndham-Thomas July 26, 2021 1 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 27, 2021. ; https://doi.org/10.1101/2020.07.17.20156034 doi: medRxiv preprint NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.